NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
290 hedge funds and large institutions have $3.21B invested in NuVasive, Inc. in 2020 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 92 increasing their positions, 102 reducing their positions, and 35 closing their positions.
71% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 35
18% more capital invested
Capital invested by funds: $2.72B → $3.21B (+$490M)
9% more funds holding
Funds holding: 266 → 290 (+24)
10% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 102
15% less call options, than puts
Call options by funds: $26.1M | Put options by funds: $30.6M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$56.1M |
| 2 |
Millennium Management
New York
|
+$39.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$27M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$27M |
| 5 |
Holocene Advisors
New York
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$40.9M |
| 2 |
Goldman Sachs
New York
|
-$20.6M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$12.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.7M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$10.3M |
NUVA Hedge Fund Activity: Q2 2020 in Review
290 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2020, worth a combined $3.21B — up 18% from $2.72B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new NUVA positions and 35 closed out — a net gain of 25 holders — while 92 added to existing stakes and 102 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $56.1M. The largest seller was Victory Capital Management, cutting an estimated $40.9M.
- 290 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2020, up from 266 in Q1 2020.
- Funds reported $3.21B of NuVasive, Inc. stock for Q2 2020, up 18% quarter-over-quarter.
- 60 funds opened new NuVasive, Inc. positions in Q2 2020 and 35 closed out, a net change of +25 holders.
- The largest NuVasive, Inc. buyer in Q2 2020 was HealthCor Management, an estimated $56.1M added.
- The largest NuVasive, Inc. seller in Q2 2020 was Victory Capital Management, an estimated $40.9M sold.
Based on aggregated 13F filings for Q2 2020.